S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   6799
 
                        2023-2024 Regular Sessions
 
                           I N  A S S E M B L Y
 
                                May 8, 2023
                                ___________
 
 Introduced by M. of A. PAULIN -- read once and referred to the Committee
   on Health
 
 AN  ACT  to  amend  the public health law, in relation to establishing a
   drug-induced movement disorder screening education program
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:

   Section  1.  The  public health law is amended by adding a new article
 2-C to read as follows:
                                 ARTICLE 2-C
                 DRUG-INDUCED MOVEMENT DISORDER SCREENING
                             EDUCATION PROGRAM
 SECTION 295. DRUG-INDUCED MOVEMENT DISORDER SCREENING EDUCATION PROGRAM.
   § 295. DRUG-INDUCED MOVEMENT DISORDER SCREENING EDUCATION PROGRAM.  1.
 THERE  IS HEREBY ESTABLISHED IN THE DEPARTMENT, IN CONSULTATION WITH THE
 OFFICE OF MENTAL HEALTH,  A  DRUG-INDUCED  MOVEMENT  DISORDER  SCREENING
 EDUCATION  PROGRAM.  THE  PURPOSE OF THE PROGRAM SHALL BE TO EDUCATE THE
 PUBLIC, HEALTHCARE PROFESSIONALS, MENTAL  HEALTH  PROFESSIONALS,  PUBLIC
 SAFETY  OFFICIALS,  AND  PUBLIC HEALTH OFFICIALS ABOUT THE IMPORTANCE OF
 SCREENING FOR DRUG-INDUCED MOVEMENT DISORDERS, DEVELOP GUIDANCE ON CLIN-
 ICAL STANDARDS FOR TREATING DRUG-INDUCED MOVEMENT DISORDERS, AND  ELIMI-
 NATE  BIAS  AND  REDUCTION OF STIGMA FOR PEOPLE LIVING WITH DRUG-INDUCED
 MOVEMENT DISORDERS RELATED TO THE TREATMENT OF MENTAL HEALTH CONDITIONS.
   2. FOR PURPOSES OF THIS SECTION, THE FOLLOWING TERMS  SHALL  HAVE  THE
 FOLLOWING MEANINGS:
   (A)  "DRUG-INDUCED MOVEMENT DISORDERS" MEANS A RANGE OF DRUG REACTIONS
 CHARACTERIZED  BY  INVOLUNTARY  OR  OTHERWISE  ABNORMAL  MOTOR  FUNCTION
 INCLUDING,  BUT  NOT  LIMITED TO, TARDIVE DYSKINESIA, MEDICATION-INDUCED
 PARKINSONISM, NEUROLEPTIC MALIGNANT SYNDROME,  MEDICATION-INDUCED  ACUTE
 DYSTONIA,  MEDICATION-INDUCED  ACUTE  AKATHISIA,  TARDIVE AKATHISIA, AND
 MEDICATION-INDUCED POSTURAL TREMOR.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD10964-01-3
 A. 6799                             2
              

 
   (B) "PROGRAM"  MEANS  THE  DRUG-INDUCED  MOVEMENT  DISORDER  SCREENING
 EDUCATION  PROGRAM  ESTABLISHED  PURSUANT  TO  SUBDIVISION  ONE  OF THIS
 SECTION.
   (C)  "TELEHEALTH"  SHALL  HAVE  THE SAME MEANING AS DEFINED BY SECTION
 TWENTY-NINE HUNDRED NINETY-NINE-CC OF THIS CHAPTER.
   3. SUCH PROGRAM SHALL:
   (A) IDENTIFY EXISTING RESOURCES  FOR  IDENTIFYING  AND  SCREENING  FOR
 DRUG-INDUCED MOVEMENT DISORDERS;
   (B) DEVELOP, PUBLISH AND DISTRIBUTE GUIDANCE, TRAININGS AND BEST PRAC-
 TICE  DOCUMENTS  FOR  HEALTHCARE AND MENTAL HEALTH PROFESSIONALS FOR THE
 SCREENING AND TREATMENT OF DRUG-INDUCED MOVEMENT DISORDERS IN  ALIGNMENT
 WITH CLINICAL STANDARDS OF CARE;
   (C)  DEVELOP  EDUCATIONAL  MATERIALS FOR PATIENTS AND PROVIDERS ON THE
 IMPORTANCE OF SCREENING FOR DRUG-INDUCED MOVEMENT DISORDERS,  MAKE  SUCH
 EDUCATIONAL  MATERIALS AVAILABLE THROUGH LOCAL DEPARTMENTS OF HEALTH AND
 MENTAL HYGIENE, AND ON THE WEBSITES OF THE DEPARTMENT AND THE OFFICE  OF
 MENTAL HEALTH;
   (D)  CREATE  AN EDUCATIONAL CAMPAIGN TO RAISE AWARENESS AND COMBAT THE
 STIGMA ASSOCIATED WITH DRUG-INDUCED MOVEMENT DISORDERS CAUSED BY  TREAT-
 ING MENTAL HEALTH CONDITIONS; AND
   (E)  DEVELOP  EDUCATIONAL  MATERIALS  AND  TRAINING  PROGRAMS  FOR LAW
 ENFORCEMENT AND PUBLIC SAFETY OFFICIALS TO ASSIST  THEM  IN  RECOGNIZING
 DRUG-INDUCED MOVEMENT DISORDERS.
   4.  THE  DEPARTMENT SHALL PERIODICALLY REVIEW AVAILABLE DATA AND CLIN-
 ICAL STANDARDS OF CARE FOR THE SYMPTOMS,  DIAGNOSIS,  AND  TREATMENT  OF
 DRUG-INDUCED MOVEMENT DISORDERS AND UPDATE THE GUIDANCE, TRAININGS, BEST
 PRACTICE DOCUMENTS, AND EDUCATIONAL MATERIALS REQUIRED UNDER SUBDIVISION
 THREE OF THIS SECTION.
   5.  THE  COMMISSIONER,  IN  CONSULTATION  WITH THE COMMISSIONER OF THE
 OFFICE OF MENTAL HEALTH, THE COMMISSIONER OF  THE  OFFICE  OF  ADDICTION
 SERVICES  AND  SUPPORTS,  THE COMMISSIONER OF THE OFFICE FOR PEOPLE WITH
 DEVELOPMENTAL DISABILITIES, AND THE  COMMISSIONER  OF  THE  DIVISION  OF
 CRIMINAL  JUSTICE  SERVICES,  SHALL PROMULGATE ANY RULES AND REGULATIONS
 WHICH MAY BE NECESSARY TO EFFECTUATE THE PROVISIONS OF THIS SECTION.
   6. IMPLEMENTATION OF THIS ACT SHALL BE SUBJECT TO, AND CONDUCTED WITH-
 IN, APPROPRIATIONS MADE THEREFOR.
   7. THE COMMISSIONER, IN CONSULTATION WITH THE COMMISSIONER  OF  MENTAL
 HEALTH, SHALL PROMULGATE RULES AND/OR REGULATIONS TO ENSURE THAT THE USE
 OF  TELEHEALTH  FOR PATIENTS AT RISK OF DEVELOPING DRUG-INDUCED MOVEMENT
 DISORDERS, INCLUDING PERSONS TREATED WITH ANTIPSYCHOTIC MEDICATIONS  FOR
 MENTAL  HEALTH  CONDITIONS,  ALIGN  WITH  EXISTING CLINICAL STANDARDS OF
 CARE.  SUCH STANDARDS OF CARE SHALL INCLUDE CONSIDERATION  OF  THE  MOST
 APPROPRIATE  CLINICAL APPROACH FOR DIFFERENT DISEASE STATES, ENSURE THAT
 SCREENINGS FOR DRUG-INDUCED MOVEMENT DISORDERS CONDUCTED VIA TELEHEALTH,
 INCLUDING VIA AUDIO-ONLY TECHNOLOGY, MEET EXISTING CLINICAL STANDARDS OF
 CARE, AND CONSIDERATION OF HOW BEST TO BALANCE PERIODIC IN-PERSON VISITS
 WITH TELEHEALTH TO ENSURE PROPER  SCREENING  FOR  DRUG-INDUCED  MOVEMENT
 DISORDERS.
   §  2.  This  act shall take effect on the ninetieth day after it shall
 have become a law. Effective immediately, the addition, amendment and/or
 repeal of any rule or regulation necessary  for  the  implementation  of
 this  act  on its effective date are authorized to be made and completed
 on or before such effective date.